← Leaderboards
Jay Wimalasena Wimalasena
University Of Tennessee Knoxville
$847,467
Attributed
$847,467
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$847,467 · 1
By mechanism
R01$847,467 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Tennessee Knoxville
Same institution · by research overlap
- Michael F McEntee$485,025
- Carla S Sommardahl$199,267
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisBcl2 Gene /ProteinBreast NeoplasmsCell CycleCell Growth RegulationCyclin Dependent KinaseEstradiolEstrogen InhibitorHormone Regulation /Control MechanismMcf7 CellMicrotubulesNeoplastic CellOvary NeoplasmsP53 Gene /ProteinPaclitaxelProtooncogene
Grant awards (4)
APOPTOSIS &CELL CYCLE IN BREAST &OVARIAN CANCER CELLS$209,107
R01 · FY2003 · CA
APOPTOSIS &CELL CYCLE IN BREAST &OVARIAN CANCER CELLS$203,335
R01 · FY2002 · CA
APOPTOSIS &CELL CYCLE IN BREAST &OVARIAN CANCER CELLS$197,732
R01 · FY2001 · CA
APOPTOSIS &CELL CYCLE IN BREAST &OVARIAN CANCER CELLS$237,293
R01 · FY2000 · CA